Imagion Biosystems was admitted to the Official List of ASX Limited (ASX) today.
View the ASX Notice of Imagion Biosystems Limited — Admission and Commencement of Official Quotation
Imagion Biosystems Delivers Major Milestone — IND Application Lodged with U.S. FDA for Phase 2 Trial of MagSense® HER2 Imaging Agent
January 31, 2026
Imagion Biosystems Hits Major Milestone, Submits IND Application to U.S. FDA for Phase 2 Trial of MagSense® HER2 Imaging Agent Key Highlights: Imagion Biosystems has